Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Oct;13(10):706-11.
doi: 10.1111/j.1477-2574.2011.00357.x. Epub 2011 Jul 22.

Ketamine does not inhibit interleukin-6 synthesis in hepatic resections requiring a temporary porto-arterial occlusion (Pringle manoeuvre): a controlled, prospective, randomized, double-blinded study

Affiliations
Randomized Controlled Trial

Ketamine does not inhibit interleukin-6 synthesis in hepatic resections requiring a temporary porto-arterial occlusion (Pringle manoeuvre): a controlled, prospective, randomized, double-blinded study

Francisco Carlos Bonofiglio et al. HPB (Oxford). 2011 Oct.

Abstract

Introduction: Previous studies have shown that interleukin-6 (IL-6) levels correlated with mortality in critically ill patients.

Goal: To determine the effect of ketamine on IL-6 levels in liver resections patients with a temporary porto-arterial occlusion (Pringle manoeuvre).

Materials and methods: Controlled, prospective, randomized, double-blinded study. One group (n = 21) received ketamine whereas the other group (n = 17) received placebo. IL-6 levels were obtained at baseline, 4, 12, 24 h, 3 and 5 days.

Results: There were no significant differences in IL-6 levels between the groups (basal P = 089, 4 hP = 0.83, 12 h P = 0.39, 24 h, P = 0.55, 3 days P = 0.80 and 5 days P = 0.45). Both groups had elevated IL-6 levels that became almost undetectable by day 5. There was no major morbidity and no mortality in either group.

Conclusions: Ketamine does not seem to have an effect on plasma levels of IL-6. This could be interpreted as a potential finding associated with outcome as we did not encounter any deaths or major complications. Further studies will likely be needed to determine the range of IL-6 levels associated with survival and mortality, and whether it could be a predictor of survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT diagram detailing the study. Placebo group: males n = 12, memales n = 8. Ketamine group: males n = 12, females n = 10. (a) one patient with a haematocrit <20% for >30 min during surgery. Two patients did not require the Pringle manoeuver. (b) One patient did not undergo the planned surgical procedure
Figure 2
Figure 2
Line graph comparing plasma levels of interleukin-6 (IL 6) (in pg/ml) for both groups of the study

References

    1. Lotar Jacob JL, Robert H. Hepatectomie droite reglee. Presse Med. 1952;60:549–551. - PubMed
    1. Foster J, Berman M. Solid liver tumors. Major Probl Clin Surg. 1977;22:342–343. - PubMed
    1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–318. - PMC - PubMed
    1. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg. 1995;19:59–71. - PubMed
    1. Fong Y. Surgical therapy of hepatic colorectal metastases. CA Cancer J Clin. 1999;49:231–255. - PubMed

Publication types